Shopping Cart
Remove All
Your shopping cart is currently empty
LY231617 is an orally bioavailable, blood-brain barrier-penetrant antioxidant that mitigates systemic ischaemic neuronal injury in rats. It exerts neuroprotective effects against H₂O₂-induced toxicity by inhibiting lipid peroxidation.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $32 | - | In Stock | |
| 5 mg | $73 | - | In Stock | |
| 10 mg | $113 | - | In Stock | |
| 25 mg | $239 | - | In Stock | |
| 50 mg | $347 | - | In Stock | |
| 100 mg | $538 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $80 | - | In Stock |
| Description | LY231617 is an orally bioavailable, blood-brain barrier-penetrant antioxidant that mitigates systemic ischaemic neuronal injury in rats. It exerts neuroprotective effects against H₂O₂-induced toxicity by inhibiting lipid peroxidation. |
| In vitro | After co-incubation with hippocampal cells overnight, LY231617 (0.25-25 μM) attenuated the toxicity of H₂O₂ on hippocampal cell cultures, with the most significant effect observed at 10 μM [1]. Overnight incubation with LY231617 (5 μM) inhibited prostaglandin production in 8-parazacco spilurus subsp. spilurus and prevented glutathione depletion [1]. |
| In vivo | In the rat four-vessel occlusion model, LY231617 (50 mg/kg) administered orally 30 minutes before ischemia significantly alleviated neuronal damage [2]. LY231617 (20 mg/kg) administered intravenously 30 minutes after ischemia effectively protected the hippocampus and striatum from damage caused by four-vessel occlusion [2]. |
| Synonyms | LY-231617 |
| Molecular Weight | 299.88 |
| Formula | C17H30ClNO |
| Cas No. | 141545-89-3 |
| Smiles | Cl.OC=1C(=CC(=CC1C(C)(C)C)CNCC)C(C)(C)C |
| Relative Density. | no data available |
| Color | Yellow |
| Appearance | Solid |
| Storage | store under nitrogen | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 200 mg/mL (666.93 mM), Sonication is recommended. Ethanol: <29.99 mg/mL, Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5 mg/mL (16.67 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.